DxCon is the leading forum for advanced diagnostics reimbursement
Join our next gathering
in Manhattan Beach, CA - September 26-27, 2024
Attended by executive thought leaders and innovative companies, the 2024 DxCon feature a lineup of experts from payers, leading diagnostics companies and firms working to advance the industry.
In parallel to the main conference, exclusive panels with payer medical directors, are open on a first-come basis to companies seeking an unmatched opportunity to learn about reimbursement direct from the source.
About DxCon
Advancing Market Access for Diagnostics
DxCON IS THE PREMIER VENUE FOR THOUGHT LEADERS AND EXECUTIVES in personalized medicine seeking to successfully launch and grow new diagnostics. Hosted by AccessDx®, participants bring perspectives from leading diagnostic companies, pharmaceutical manufacturers, payers, and other stakeholders.
The 2024 edition will explore the rise of companion diagnostics and how pharma and diagnostics companies can collaborate to increase opportunities in a growing market.
Attendees will build their networks with decision makers in interactive professional and social settings, and come away better equipped to address opportunities and challenges in the diagnostics marketplace.
DxCon is ideal for executives from diagnostics and pharmaceutical manufacturers, as well as Medical Directors, Reimbursement Directors, Case Managers, Sales and Marketing Directors, and leaders from other healthcare organizations with a strategic investment in diagnostics.
The event will be held September 26-27, 2024 in Manhattan Beach, California.
Registration Rate:
$1,895 - Early Bird
$2,195 - Standard Rate
Please contact us for Group Discounts.
ACCOMMODATIONS: A block of hotel rooms and reservations for DxCon is available to book online here.
”The DxConference discussions were immediately applicable to our team.“
Vice President, Market Access
Delivering on the Promise of Personalized Medicine®
We believe that personalized medicine is talked about a lot but not done enough. We have gathered industry leaders to assist you (diagnostic innovators and manufacturers) in successfully launching personalized medicine diagnostics (PMDx) in the United States.
Healthcare is one of the most intricate and constantly changing areas of the law. For nearly seven decades, Foley Hoag has kept its healthcare clients ahead of the shifts and out of the gray areas with an approach built on its deep understanding of healthcare law and a strong tradition of developing innovative legal solutions to your needs.
At 21st Century Medicine, our mission is to improve the quality of healthcare by encouraging research, development, and commercialization of innovative diagnostic technologies that personalize patient care, improve patient outcomes, and substantially reduce healthcare costs.
